Literature DB >> 4106191

Colorimetric determination of serum acid phosphatase activity using adenosine 3'-monophosphate as substrate.

G Ellis, A Belfield, D M Goldberg.   

Abstract

The hydrolysis of adenosine 3'-monophosphate by serum acid phosphatase has been coupled to the liberation of ammonia from the adenosine generated through the action of exogenous adenosine deaminase. The ammonia is measured at the end of the incubation by a modification of the phenol-hypochlorite reaction of Berthelot. Optimum conditions for the enzyme reaction have been defined. Inhibition of the Berthelot reaction by the serum used in the assay is small, and may be compensated by a correction factor. Although the value for the control is high in relation to the test over the normal range, this is largely outweighed by the good sensitivity and precision of the method. The substrate is not significantly hydrolysed by erythrocyte acid phosphatase within the limits encountered in haemolysed sera. Experience of the method in routine hospital diagnosis compared favorably with that of a standard method employing disodium phenyl phosphate as substrate. It is suggested that activities greater than 3.1 IU/l should be further investigated and those greater than 3.7 IU/l should be regarded as definitely raised. The stability of human serum AcPase when promptly separated and held at 4 degrees C or - 20 degrees C was confirmed. At room temperature, acidification to pH 6.0 greatly improved stability.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4106191      PMCID: PMC477079          DOI: 10.1136/jcp.24.6.493

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  31 in total

1.  Modified reagents for determination of urea and ammonia.

Authors:  A L CHANEY; E P MARBACH
Journal:  Clin Chem       Date:  1962-04       Impact factor: 8.327

2.  The determination of tartrate-inhibited phosphatase in serum.

Authors:  K JACOBSSON
Journal:  Scand J Clin Lab Invest       Date:  1960       Impact factor: 1.713

3.  Inhibition of prostatic acid phosphatase by alpha-hydroxycarboxylic acids.

Authors:  G S KILSHEIMER; B AXELROD
Journal:  J Biol Chem       Date:  1957-08       Impact factor: 5.157

4.  AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND.

Authors:  A B Gutman; E B Gutman
Journal:  J Clin Invest       Date:  1938-07       Impact factor: 14.808

5.  Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma.

Authors:  G P Murphy; G Reynoso; G M Kenny; J F Gaeta
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

Review 6.  Chemical tests in the diagnosis of prostatic carcinoma.

Authors:  G R Prout
Journal:  JAMA       Date:  1969-09-15       Impact factor: 56.272

7.  Hydrolysis of adenosine monophosphates by acid phosphatases as measured by a continuous spectrophotometric assay.

Authors:  A Belfield; D M Goldberg
Journal:  Biochem Med       Date:  1970-09

8.  The acid phosphatase isoenzymes in normal and pathological sera and in tissue homogenates.

Authors:  L Rozenszajn; Y Epstein; D Shoham; I Arber
Journal:  J Lab Clin Med       Date:  1968-11

9.  Lysosomal acid pyrophosphatase and acid phosphatase.

Authors:  R Brightwell; A L Tappel
Journal:  Arch Biochem Biophys       Date:  1968-03-20       Impact factor: 4.013

10.  Serum acid alpha-naphthyl phosphatase activity.

Authors:  E Amador; J W Price; G Marshall
Journal:  Am J Clin Pathol       Date:  1969-02       Impact factor: 2.493

View more
  3 in total

1.  An assessment of serum acid and alkaline phosphatase determinations in prostatic cancer with a clinical validation of an acid phosphatase assay utilizing adenosine 3'-monophosphate as substrate.

Authors:  D M Goldberg; G Ellis
Journal:  J Clin Pathol       Date:  1974-02       Impact factor: 3.411

2.  Kinetic Studies of Newly Patented Aminoalkanol Derivatives with Potential Anticancer Activity as Competitive Inhibitors of Prostate Acid Phosphatase.

Authors:  Błażej Grodner; Mariola Napiórkowska; Dariusz Maciej Pisklak
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

3.  Ameliorating effect of the biological Zinc nanoparticles in abamectin induced hepato-renal injury in a rat model: Implication of oxidative stress, biochemical markers and COX-2 signaling pathways.

Authors:  Ahmed A A Aioub; Sameh A Abdelnour; Mustafa Shukry; Ahmed M Saad; Mohamed T El-Saadony; Zhongli Chen; Ahmed E A Elsobki
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.